Memphis Pharmaceuticals and Chemical Industries achieved a net profit after tax of EGP 375.756 million during the nine months ending last March, compared to EGP 166.368 million during the same period of the previous year, an increase of 125.9%. According to the income statement sent to the Egyptian Exchange, gross profit rose by 120.7% to reach EGP 507.305 million during the period from July 2024 to March 2025, compared to EGP 229.864 million in the corresponding period. Company revenues also increased by 65.1% to record EGP 1.097 billion, compared to EGP 665.577 million in the same period last year, with the gross profit to revenue ratio reaching 46.2% compared to 34.6% in the corresponding period.
